Payments to Acquire Property, Plant, and Equipment of Adaptimmune Therapeutics PLC from 30 Jun 2013 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Adaptimmune Therapeutics PLC quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 30 Jun 2013 to 31 Mar 2025.
  • Adaptimmune Therapeutics PLC Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $1,203,000, a 1079% increase year-over-year.
  • Adaptimmune Therapeutics PLC annual Payments to Acquire Property, Plant, and Equipment for 2024 was $886,000, a 81% decline from 2023.
  • Adaptimmune Therapeutics PLC annual Payments to Acquire Property, Plant, and Equipment for 2023 was $4,681,000, a 84% decline from 2022.
  • Adaptimmune Therapeutics PLC annual Payments to Acquire Property, Plant, and Equipment for 2022 was $29,496,000, a 244% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Adaptimmune Therapeutics PLC Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,203,000 +$1,101,000 +1079% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $102,000 -$2,247,000 -96% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $2,349,000 -$4,765,000 -67% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2022 $7,114,000 +$5,962,000 +518% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $1,152,000 +$960,000 +500% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $192,000 -$712,000 -79% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $904,000 -$1,000,000 -53% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q1 2018 $1,904,000 -$10,345,000 -84% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
Q1 2017 $12,249,000 +$10,541,000 +617% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q1 2016 $1,708,000 +$1,036,000 +154% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $672,000 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1

Adaptimmune Therapeutics PLC Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $886,000 -$3,795,000 -81% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2023 $4,681,000 -$24,815,000 -84% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 $29,496,000 +$20,922,000 +244% 01 Jan 2022 31 Dec 2022 10-K 24 Mar 2025 2024 FY
2021 $8,574,000 +$6,233,000 +266% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2024 2023 FY
2020 $2,341,000 +$749,000 +47% 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023 2022 FY
2019 $1,592,000 -$2,318,000 -59% 01 Jan 2019 31 Dec 2019 10-K 14 Mar 2022 2021 FY
2018 $3,910,000 -$20,733,000 -84% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $24,643,000 +$13,137,000 +114% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2019 2018 FY
2016 $11,506,000 +$6,426,000 +126% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $5,080,000 +$3,714,000 +272% 01 Jul 2014 30 Jun 2015 10-K 15 Mar 2018 2017 FY
2014 $1,366,000 +$1,199,000 +718% 01 Jul 2013 30 Jun 2014 10-K 13 Mar 2017 2016 FY
2013 $167,000 01 Jul 2012 30 Jun 2013 8-K 08 Jul 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.